Nozha International Hospital (EGX:NINH)
Egypt · Delayed Price · Currency is EGP 17.12
-0.16 (-0.93%)
At close: Nov 12, 2026
EGX:NINH Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 563.75 | 525.48 | 432.42 | 362.29 | 295.8 | 250.5 | |
Revenue Growth | 11.24% | 21.52% | 19.36% | 22.48% | 18.09% | 15.43% |
Cost of Revenue | 377.33 | 352.93 | 306.01 | 252.33 | 213.44 | 162.66 |
Gross Profit | 186.42 | 172.55 | 126.41 | 109.96 | 82.36 | 87.84 |
Selling, General & Admin | 35.36 | 32.74 | 29.48 | 25.11 | 20.46 | 15.44 |
Other Operating Expenses | - | - | - | -1.02 | - | - |
Operating Expenses | 37.35 | 34.38 | 31.71 | 26.74 | 20.94 | 15.74 |
Operating Income | 149.07 | 138.17 | 94.7 | 83.22 | 61.42 | 72.1 |
Interest & Investment Income | 95.87 | 85.12 | 59.22 | 40.39 | 22.63 | 12.82 |
Other Non Operating Income (Expenses) | 1.93 | 0.84 | 0.14 | -1.82 | 0.77 | 1.27 |
EBT Excluding Unusual Items | 246.88 | 224.12 | 154.06 | 121.8 | 84.82 | 86.18 |
Gain (Loss) on Sale of Assets | 1.15 | 1.76 | 0.62 | 0.31 | 0.28 | 0.03 |
Pretax Income | 248.03 | 225.88 | 154.68 | 122.11 | 85.1 | 86.22 |
Income Tax Expense | 56.46 | 51.68 | 37.01 | 30.6 | 21.58 | 20.33 |
Net Income | 191.56 | 174.19 | 117.66 | 91.51 | 63.52 | 65.88 |
Preferred Dividends & Other Adjustments | 5.42 | 12.97 | 9.09 | 8.06 | 6.89 | 5.84 |
Net Income to Common | 186.14 | 161.22 | 108.58 | 83.46 | 56.63 | 60.05 |
Net Income Growth | 25.65% | 48.49% | 30.10% | 47.38% | -5.69% | 33.22% |
Shares Outstanding (Basic) | 320 | 300 | 300 | 300 | 300 | 300 |
Shares Outstanding (Diluted) | 320 | 300 | 300 | 300 | 300 | 300 |
Shares Change | 6.52% | - | - | - | -0.00% | - |
EPS (Basic) | 0.58 | 0.54 | 0.36 | 0.28 | 0.19 | 0.20 |
EPS (Diluted) | 0.58 | 0.54 | 0.36 | 0.28 | 0.19 | 0.20 |
EPS Growth | 17.96% | 48.49% | 30.10% | 47.38% | -5.69% | 33.22% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 135.12 | 151.68 | 77.02 | 17.66 | 25.77 | 66.96 |
Free Cash Flow Per Share | 0.42 | 0.51 | 0.26 | 0.06 | 0.09 | 0.22 |
Dividend Per Share | - | - | 0.073 | - | - | 0.018 |
Dividend Growth | - | - | - | - | - | - |
Gross Margin | 33.07% | 32.84% | 29.23% | 30.35% | 27.84% | 35.07% |
Operating Margin | 26.44% | 26.29% | 21.90% | 22.97% | 20.76% | 28.78% |
Profit Margin | 33.02% | 30.68% | 25.11% | 23.04% | 19.14% | 23.97% |
Free Cash Flow Margin | 23.97% | 28.87% | 17.81% | 4.87% | 8.71% | 26.73% |
EBITDA | 161.88 | 149.13 | 104.59 | 90.9 | 67.61 | 78.29 |
EBITDA Margin | 28.72% | 28.38% | 24.19% | 25.09% | 22.86% | 31.26% |
D&A For EBITDA | 12.81 | 10.96 | 9.89 | 7.68 | 6.2 | 6.2 |
EBIT | 149.07 | 138.17 | 94.7 | 83.22 | 61.42 | 72.1 |
EBIT Margin | 26.44% | 26.29% | 21.90% | 22.97% | 20.76% | 28.78% |
Effective Tax Rate | 22.77% | 22.88% | 23.93% | 25.06% | 25.36% | 23.58% |